<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls?" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/are-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/are-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-08-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls?" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2015-08-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls?","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/are-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal/"},"url":"https://clinicaltree.github.io/posts/are-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal/"}</script><title>Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls? | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls?</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Are Transversal MR Images Sufficient to Distinguish Persons with Mild Cognitive Impairment From Healthy Controls?</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1441040400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Aug 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Christoph Mönninghoff MD</a> </em>, <em> <a href="">Martha Dlugaj PhD</a> </em>, <em> <a href="">Oliver Kraff PhD</a> </em>, <em> <a href="">Marie Henrike Geisel MSc</a> </em>, <em> <a href="">Karl-Heinz Jöckel PhD</a> </em>, <em> <a href="">Raimund Erbel MD</a> </em>, <em> <a href="">Christian Weimar MD</a> </em>, <em> <a href="">Isabel Wanke MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="3219 words"> <em>17 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Mild cognitive impairment (MCI) is associated with an increased risk of developing dementia. This study aims to determine whether current standard magnetic resonance imaging (MRI) is providing markers that can distinguish between subjects with amnestic MCI (aMCI), nonamnestic MCI (naMCI), and healthy controls (HCs).</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A subset of 126 MCI subjects and 126 age-, gender-, and education-appropriate HCs (mean age, 70.9 years) were recruited from 4157 participants in the longitudinal community-based Heinz Nixdorf Recall Study. The burden of white matter hyperintensities (WMHs), cerebral microbleeds, and brain atrophy was evaluated on transversal MR images from a single 1.5-T MR scanner by two blinded neuroradiologists. Logistic regression and receiver-operating characteristic analysis were used for statistical analysis.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Occipital WMH burden was significantly increased in aMCI, but not in naMCI relative to HCs ( <em>P</em> = .01). The combined MCI group showed brain atrophy relative to HCs ( <em>P</em> = .01) pronounced at caudate nuclei ( <em>P</em> = .01) and temporal horn level ( <em>P</em> = .004) of aMCI patients and increased at the frontal and occipital horns of naMCI patients compared to either aMCI or HCs. Microbleeds were equally distributed in the MCI and control group, but more frequent in aMCI (22 of 84) compared to naMCI subjects (3 of 23).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In his cohort, increased occipital WMHs and cortical and subcortical brain atrophies at temporal horn and caudate nuclei level distinguished aMCI from naMCI subjects and controls. Volumetric indices appear of interest and should be assessed under reproducible conditions to gain diagnostic accuracy.</p><p>Mild cognitive impairment (MCI) describes a transitional state between cognitive changes of normal aging and dementia, especially Alzheimer disease (AD) . Hence, MCI is a risk factor for dementia with an estimated conversion rate of 10%–15% per year, compared to 1%–2% in the cognitively normal, elderly population . This prodromal AD state is diagnosed in the clinical setting by neurologic and neuropsychological assessment . Nonamnestic forms of MCI (naMCI) have shown findings related to vascular disease, whereas amnestic MCI (aMCI) subjects demonstrated demographic, genetic, and magnetic resonance imaging (MRI) characteristics similar to AD pathology . Despite a controversial definition of MCI as a diagnostic entity, because it does not constitute a homogeneous clinical syndrome, it is an ideal target for prevention and future therapies of dementia . An early diagnosis and differentiation of MCI subtypes may have a major impact on the selection of suitable prospective therapies in future. MRI examinations are not routinely included in clinical work-up of MCI, although brain tissue and brain volumetric changes may help to predict conversion from MCI to dementia . Cerebral microbleeds (CMBs) are often in focus of MR studies dealing with neurodegenerative diseases and dementia, but their predictive value in MCI or AD-converters remains unclear . Medial temporal lobe atrophy has been shown to be an important predictor for conversion from MCI to AD . The volume of the hippocampus, the entorhinal cortex, and amygdala is known to decline in early stages of AD . We hypothesized that the degrees of brain atrophy and the burden of white matter hyperintensities (WMHs) and CMBs on transversal 1.5-T MR images correlate with the clinical diagnosis of MCI. Thus, we compared MR signs in subjects with MCI (divided into amnestic and nonamnestic subtypes because of the different underlying etiology) with age-, gender-, and education-matched controls on transversal fluid-attenuated inversion recovery (FLAIR) and T2*-weighted images in a large German population-based study. This study aims to determine whether current standard MRI is providing markers that can distinguish between subjects with aMCI, naMCI, and HCs in a single study.</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population-and-sampling-procedure"><span class="mr-2">Study Population and Sampling Procedure</span><a href="#study-population-and-sampling-procedure" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The Heinz Nixdorf Recall (HNR; Risk Factors, Evaluation of Coronary Calcium and Lifestyle) study is a population-based prospective cohort study with 4814 subjects (age range, 45–75 years) randomly selected from mandatory lists of residence in the Ruhr area in Germany . The major aim of the HNR study was to evaluate the predictive value of coronary artery calcification using electron-beam computed tomography for myocardial infarction and cardiac death in comparison to cardiovascular risk factors. Study methods have been described elsewhere in detail .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="diagnostic-classifications-and-covariates"><span class="mr-2">Diagnostic Classifications and Covariates</span><a href="#diagnostic-classifications-and-covariates" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-imaging-techniques-and-examination-protocols"><span class="mr-2">MR Imaging Techniques and Examination Protocols</span><a href="#mr-imaging-techniques-and-examination-protocols" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-image-assessment"><span class="mr-2">MR Image Assessment</span><a href="#mr-image-assessment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-methods"><span class="mr-2">Statistical Methods</span><a href="#statistical-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="descriptive-statistics"><span class="mr-2">Descriptive Statistics</span><a href="#descriptive-statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Characteristics of Subjects with MCI and Controls and Stratified by the Two MCI Subgroups</p><p>Parameter MCI Total ( <em>n</em> = 126) Controls ( <em>n</em> = 126)<em>P</em> Value, MCI Versus Controls MCI, Amnestic ( <em>n</em> = 93) MCI, Nonamnestic ( <em>n</em> = 33)<em>P</em> Value, aMCI Versus naMCI Age, y, mean ± SD 70.9 ± 6.4 70.8 ± 6.4 Matched 72.3 ± 5.6 66.9 ± 7.0<strong>&lt;.0001</strong> Gender (%) Male 74 (59) 74 (59) 58 (62) 16 (48) Female 52 (41) 52 (41) Matched 35 (38) 17 (52) .17 Education (%) ≤10 y 28 (22) 21 (17) 17 (18) 11 (33) 11–13 y 80 (64) 75 (60) 62 (67) 18 (55) ≥14 y 18 (14) 30 (24) Matched 14 (15) 4 (12) .22 Marital status (%) Single 2 (2) 7 (6) 2 (2) 0 (0) Married 87 (70) 91 (72) 63 (68) 24 (75) Divorced or in separation 10 (8) 8 (6) 6 (7) 4 (139) Widowed 25 (20) 20 (16) Matched 21 (23) 4 (13) .30 CHD (%) Yes 18 (14) 17 (13) 12 (13) 5 (15) No 108 (86) 109 (87) .86 81 (87) 28 (85) .75 Hypertension (JNC7) None 76 (60) 75 (60) ∗ 53 (57) 22 (69) Stage 1 or 2 50 (40) 50 (40) &gt;.99 40 (43) 10 (31) .24</p><p>aMCI, amnestic MCI; CHD, coronary heart disease; JNC7, hypertension defined according to “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”; MCI, mild cognitive impairment; naMCI, nonamnestic MCI; SD, standard deviation.</p><p>Data are presented as mean age (±standard deviation) and number (percentage) of study participants.</p><p>Significant <em>P</em> values are presented in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="white-matter-hyperintensities"><span class="mr-2">White Matter Hyperintensities</span><a href="#white-matter-hyperintensities" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AreTransversalMRImagesSufficienttoDistinguishPersonswithMildCognitiveImpairmentFromHealthyControls/0_1s20S1076633215002123.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AreTransversalMRImagesSufficienttoDistinguishPersonswithMildCognitiveImpairmentFromHealthyControls/0_1s20S1076633215002123.jpg" alt="Figure 1, Fluid-attenuated inversion recovery images of a 79-year-old female amnestic mild cognitive impairment subject ( right ) with large confluent white matter hyperintensities (WMHs) around both lateral ventricles and with low cortical brain atrophy compared to her matched control ( left ) without WMHs and without significant cortical brain atrophy." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Periventricular WMHs in MCI Subjects (Total and Stratified by Subgroups) and Matched Controls Subdivided in 3 Periventricular Regions and 4 Size Classes</p><p>Periventricular WMHs MCI Total ( <em>n</em> = 126) Controls ( <em>n</em> = 126)<em>P</em> Value Amnestic MCI ( <em>n</em> = 93) Nonamnestic MCI ( <em>n</em> = 33)<em>P</em> Value, aMCI Versus naMCI</p><p>(Adj.)<em>P</em> Value, aMCI Versus Controls_P_ Value, naMCI Versus Controls Frontal None/pencil thin 95 (75) 95 (75) 70 (76) 25 (76) Smooth halo 27 (22) 26 (21) 19 (20) 8 (24) Confluent 4 (3) 5 (4) .97 4 (4) 0 (0) .20 .99 .68 Lateral None/pencil thin 91 (72) 96 (76) 65 (70) 26 (79) Smooth halo 31 (25) 28 (22) 24 (26) 7 (21) Confluent 4 (3) 2 (2) .74 4 (4) 0 (0) .29 .81 .72 Occipital None/pencil thin 24 (19) 28 (22) 20 (22) 4 (12) Smooth halo 17 (14) 9 (7) 14 (15) 3 (9) Confluent 13 (10) 4 (3)<strong>.02</strong> 11 (12) 2 (6) .55<strong>.01</strong> .90</p><p>Adj, age adjusted; aMCI, amnestic MCI; MCI, mild cognitive impairment; naMCI, nonamnestic MCI; WMH, white matter hyperintensity.</p><p>Data are presented as number of study participants (percentage). Significant <em>P</em> values are presented in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cortical-and-subcortical-brain-atrophy"><span class="mr-2">Cortical and Subcortical Brain Atrophy</span><a href="#cortical-and-subcortical-brain-atrophy" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Brain Atrophy on Axial FLAIR Images Estimated on a Four-Point Scale</p><p>Brain Atrophy Estimation MCI Total ( <em>n</em> = 126) Matched Controls ( <em>n</em> = 126)<em>P</em> Value Amnestic MCI ( <em>n</em> = 93) Nonamnestic MCI ( <em>n</em> = 33)<em>P</em> Value, aMCI Versus naMCI (Adj.)<em>P</em> Value, aMCI Versus Controls_P_ Value, naMCI Versus Controls None 46 (36) 59 (47) 27 (29) 19 (58) Low 39 (31) 43 (34) 32 (34) 7 (21) Moderate 30 (24) 22 (17) 25 (27) 5 (15) Severe 11 (9) 2 (2)<strong>.01</strong> 9 (10) 2 (6) .79<strong>.03</strong> .33</p><p>Adj, age adjusted; aMCI, amnestic MCI; FLAIR, fluid-attenuated inversion recovery; MCI, mild cognitive impairment; naMCI, nonamnestic MCI.</p><p>Data are presented as number (percentage) of study participants. Significant <em>P</em> values are presented in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Ventricle and Brain Diameter, Ventricle-to-Brain Ratio at Three Levels, and rWTH to Assess Subcortical Brain Atrophy in aMCI, naMCI, and Matched Controls</p><p>Subcortical Brain Atrophy, mm, Mean ± SD MCI Total ( <em>n</em> = 126) Matched Controls ( <em>n</em> = 126)<em>P</em> Value Amnestic MCI ( <em>n</em> = 93) Nonamnestic MCI ( <em>n</em> = 33)<em>P</em> Value, aMCI Versus naMCI (Adj.)<em>P</em> Value, aMCI Versus Controls_P_ Value, naMCI Versus Controls Frontal horn level Ventricle 36.35 ± 5.71 37.98 ± 7.49<strong>.03</strong> 37.26 ± 4.89 33.79 ± 7.04<strong>.03</strong> .17<strong>.04</strong> Brain 106.07 ± 10.56 107.53 ± 8.20 .19 107.38 ± 4.34 102.39 ± 19.04<strong>.01</strong> .74 .09 Ventricle/brain ratio 0.34 ± 0.05 0.37 ± 0.23 .09 0.35 ± 0.04 0.32 ± 0.07 .11 .23 .07 Occipital horn level Ventricle 61.32 ± 8.35 63.41 ± 6.18<strong>.02</strong> 62.54 ± 6.41 57.88 ± 11.74<strong>.01</strong> .20<strong>.02</strong> Brain 125.88 ± 12.78 128.36 ± 6.09<strong>.02</strong> 127.20 ± 5.72 122.15 ± 22.90<strong>.01</strong> .14 .07 Ventricle/brain ratio 0.48 ± 0.06 0.49 ± 0.04 .07 0.49 ± 0.05 0.46 ± 0.09<strong>.049</strong> .53<strong>.04</strong> Caudate nuclei level Ventricle 18.38 ± 4.57 17.83 ± 3.82 .24 19.16 ± 4.34 16.18 ± 4.54 .09 .14 .88 Brain 109.79 ± 6.59 112.51 ± 6.42<strong>.0001</strong> 109.81 ± 6.67 109.76 ± 6.43 .33<strong>&lt;.0001</strong> .64 Ventricle/brain ratio 0.17 ± 0.04 0.16 ± 0.03<strong>.01</strong> 0.17 ± 0.04 0.15 ± 0.03 .30<strong>.01</strong> .64 rWTH Right 4.33 ± 1.72 3.75 ± 1.20<strong>.004</strong> 4.44 ± 1.88 4.01 ± 1.10 .56<strong>.01</strong> .30 Left 4.18 ± 1.73 3.60 ± 1.25<strong>.005</strong> 4.33 ± 1.90 3.76 ± 1.14 .85<strong>.01</strong> .17</p><p>Adj, age adjusted; aMCI, amnestic MCI; MCI, mild cognitive impairment; naMCI, nonamnestic MCI; rWTH, radial width of the temporal horn; SD, standard deviation.</p><p>Data are presented as mean values in millimeter (±standard deviation). Significant <em>P</em> values are presented in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cerebral-microbleeds"><span class="mr-2">Cerebral Microbleeds</span><a href="#cerebral-microbleeds" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AreTransversalMRImagesSufficienttoDistinguishPersonswithMildCognitiveImpairmentFromHealthyControls/1_1s20S1076633215002123.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AreTransversalMRImagesSufficienttoDistinguishPersonswithMildCognitiveImpairmentFromHealthyControls/1_1s20S1076633215002123.jpg" alt="Figure 2, Cerebral microbleeds ( arrows ) located in the occipital cortex of a 75-year-old male mild cognitive impairment subject ( right ) and normal finding of the matched control ( left ) on axial T2*-weighted images." class="lazyload" data-proofer-ignore></a></p><p>Table 5</p><p>Cerebral Microbleeds in MCI Subjects and Matched Controls and Stratified for the MCI Subgroups</p><p>Cerebral Microbleeds <em>n</em> (%) MCI <em>n</em> = 108 Controls <em>n</em> = 125<em>P</em> Value, MCI Versus Controls aMCI <em>n</em> = 83 naMCI <em>n</em> = 24<em>P</em> Value, aMCI Versus naMCI Cortex Frontal 3 (3) 5 (4) .71 2 (2) 1 (4) .77 Parietal 6 (6) 6 (5) .76 6 (7) 0 (0)<strong>.41</strong> Temporal 3 (3) 2 (2) .66 3 (4) 0 (0)<strong>.65</strong> Occipital 1 (1) 3 (2) .34 1 (1) 0 (0)<strong>&gt;.99</strong> White matter Frontal 3 (3) 5 (4) .48 3 (4) 0 (0)<strong>&gt;.99</strong> Parietal 2 (2) 3 (2) .66 2 (3) 0 (0)<strong>&gt;.99</strong> Temporal 4 (4) 2 (2) .42 3 (4) 1 (4)<strong>.38</strong> Occipital 2 (2) 1 (1) .57 2 (2) 0 (0)<strong>.69</strong> Basal ganglia 7 (6) 3 (2) .22 6 (7) 1 (4)<strong>.23</strong> Thalamus 3 (3) 1 (1) .34 3 (4) 0 (0)<strong>.42</strong> Brainstem 3 (3) 0 (0) .99 3 (4) 0 (0)<strong>.12</strong> Cerebellum 4 (4) 9 (7) .37 3 (4) 1 (4)<strong>.65</strong></p><p>aMCI, amnestic MCI; MCI, mild cognitive impairment; naMCI, nonamnestic MCI.</p><p>Data are presented as number of microbleeds (percentage). Significant <em>P</em> values are presented in bold. No T2*-weighted images were available in 18 MCI (9 aMCI/9 naMCI) subjects and in 2 control subjects.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="limitations"><span class="mr-2">Limitations</span><a href="#limitations" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Petersen R.C., Smith G.E., Waring S.C., et. al.: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: pp. 303-308.</p><li><p>2. Winblad B., Palmer K., Kivipelto M., et. al.: Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: pp. 240-246.</p><li><p>3. Petersen R.C.: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: pp. 183-194.</p><li><p>4. Petersen R.C., Doody R., Kurz A., et. al.: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: pp. 1985-1992.</p><li><p>5. He J., Farias S., Martinez O., et. al.: Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol 2009; 66: pp. 1393-1399.</p><li><p>6. Albert M.S., DeKosky S.T., Dickson D., et. al.: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: pp. 270-279.</p><li><p>7. Heister D., Brewer J.B., Magda S., et. al.: Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 2011; 77: pp. 1619-1628.</p><li><p>8. Lin A.L., Laird A.R., Fox P.T., et. al.: Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer’s disease. Neurol Res Int 2012; 2012: pp. 907409.</p><li><p>9. Schneider J.A.: Brain microbleeds and cognitive function. Stroke 2007; 38: pp. 1730-1731.</p><li><p>10. Brundel M., Heringa S.M., de Bresser J., et. al.: High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer’s Disease. J Alzheimers Dis 2012;</p><li><p>11. Ayaz M., Boikov A.S., Haacke E.M., et. al.: Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging 2010; 31: pp. 142-148.</p><li><p>12. Cordonnier C., van der Flier W.M., Sluimer J.D., et. al.: Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006; 66: pp. 1356-1360.</p><li><p>13. Kirsch W., McAuley G., Holshouser B., et. al.: Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 2009; 17: pp. 599-609.</p><li><p>14. Korf E.S., Wahlund L.O., Visser P.J., et. al.: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: pp. 94-100.</p><li><p>15. Chupin M., Gerardin E., Cuingnet R., et. al.: Fully automatic hippocampus segmentation and classification in Alzheimer’s disease and mild cognitive impairment applied on data from ADNI. Hippocampus 2009; 19: pp. 579-587.</p><li><p>16. Laakso M.P., Soininen H., Partanen K., et. al.: Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer’s disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995; 9: pp. 73-86.</p><li><p>17. Schmermund A., Mohlenkamp S., Stang A., et. al.: Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002; 144: pp. 212-218.</p><li><p>18. Dlugaj M., Weimar C., Wege N., et. al.: Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort. Dement Geriatr Cogn Disord 2010; 30: pp. 362-373.</p><li><p>19. UNESCO: International standard classification of education (ISCED).1997.</p><li><p>20. de Groot J.C., de Leeuw F.E., Oudkerk M., et. al.: Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: pp. 145-151.</p><li><p>21. Mantyla R., Erkinjuntti T., Salonen O., et. al.: Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke 1997; 28: pp. 1614-1623.</p><li><p>22. Frisoni G.B., Geroldi C., Beltramello A., et. al.: Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol 2002; 23: pp. 35-47.</p><li><p>23. Duara R., Loewenstein D.A., Potter E., et. al.: Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008; 71: pp. 1986-1992.</p><li><p>24. Aksu Y., Miller D.J., Kesidis G., et. al.: An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients. PLoS One 2011; 6: pp. e25074.</p><li><p>25. Spulber G., Niskanen E., MacDonald S., et. al.: Whole brain atrophy rate predicts progression from MCI to Alzheimer’s disease. Neurobiol Aging 2010; 31: pp. 1601-1605.</p><li><p>26. Wolz R., Julkunen V., Koikkalainen J., et. al.: Multi-method analysis of MRI images in early diagnostics of Alzheimer’s Disease. PLoS One 2011; 6: pp. e25446.</p><li><p>27. Appel J., Potter E., Bhatia N., et. al.: Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009; 30: pp. 1870-1876.</p><li><p>28. Du A.T., Schuff N., Chao L.L., et. al.: White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005; 26: pp. 553-559.</p><li><p>29. Silbert L.C., Dodge H.H., Perkins L.G., et. al.: Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012; 79: pp. 741-747.</p><li><p>30. Jacobs H.I., Visser P.J., Van Boxtel M.P., et. al.: Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging 2012; 33: pp. 201. e1-8</p><li><p>31. Mortamais M., Reynes C., Brickman A.M., et. al.: Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. PLoS One 2013; 8: pp. e56972.</p><li><p>32. Okonkwo O.C., Alosco M.L., Jerskey B.A., et. al.: Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimers Dement 2010; 6: pp. 404-411.</p><li><p>33. Misra C., Fan Y., Davatzikos C.: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009; 44: pp. 1415-1422.</p><li><p>34. Leow A.D., Yanovsky I., Parikshak N., et. al.: Alzheimer’s disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 2009; 45: pp. 645-655.</p><li><p>35. Tapiola T., Pennanen C., Tapiola M., et. al.: MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. Neurobiol Aging 2008; 29: pp. 31-38.</p><li><p>36. Eckerstrom C., Andreasson U., Olsson E., et. al.: Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment. Dement Geriatr Cogn Disord 2010; 29: pp. 294-300.</p><li><p>37. Mueller S.G., Schuff N., Yaffe K., et. al.: Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer’s disease. Hum Brain Mapp 2010; 31: pp. 1339-1347.</p><li><p>38. Gao F.Q., Black S.E., Leibovitch F.S., et. al.: Linear width of the medial temporal lobe can discriminate Alzheimer’s disease from normal aging: the Sunnybrook dementia study. Neurobiol Aging 2004; 25: pp. 441-448.</p><li><p>39. Uotani C., Sugimori K., Kobayashi K.: Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer’s disease. Psychiatry Clin Neurosci 2006; 60: pp. 319-326.</p><li><p>40. Gabryelewicz T., Pawlowska-Detko A., Misko J., et. al.: Prediction of deterioration of mild cognitive impairment with CT and SPECT. Med Sci Monit 2007; 13: pp. 31-37.</p><li><p>41. Prins N.D., van Dijk E.J., den Heijer T., et. al.: Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: pp. 1531-1534.</p><li><p>42. Boutet C., Chupin M., Colliot O., et. al.: Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer’s disease?. Neuroradiology 2012; 54: pp. 1321-1330.</p><li><p>43. Eckerstrom C., Olsson E., Bjerke M., et. al.: A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. J Alzheimers Dis 2013; 36: pp. 421-431.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-9/'>Issue 9</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Are%20Transversal%20MR%20Images%20Sufficient%20to%20Distinguish%20Persons%20with%20Mild%20Cognitive%20Impairment%20From%20Healthy%20Controls?%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fare-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Are%20Transversal%20MR%20Images%20Sufficient%20to%20Distinguish%20Persons%20with%20Mild%20Cognitive%20Impairment%20From%20Healthy%20Controls?%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fare-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fare-transversal-mr-images-sufficient-to-distinguish-persons-with-mild-cognitive-impairment-from-heal%2F&text=Are%20Transversal%20MR%20Images%20Sufficient%20to%20Distinguish%20Persons%20with%20Mild%20Cognitive%20Impairment%20From%20Healthy%20Controls?%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/3-tesla23-na-magnetic-resonance-imaging-during-aerobic-and-anaerobic-exercise/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>3 Tesla23 Na Magnetic Resonance Imaging During Aerobic and Anaerobic Exercise</h3><div class="text-muted small"><p> Rationale and Objectives The aim of the work described here was to determine the feasibility of monitoring Na + concentration and distribution in muscle/skin during aerobic/anaerobic exercise wit...</p></div></div></a></div><div class="card"> <a href="/posts/abbreviated-screening-protocol-for-breast-mri/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abbreviated Screening Protocol for Breast MRI</h3><div class="text-muted small"><p> Rationale and Objectives To compare the performance of two shortened breast magnetic resonance imaging (MRI) protocols to a standard MRI protocol for breast cancer screening. Materials and Method...</p></div></div></a></div><div class="card"> <a href="/posts/adoption-of-the-16-month-american-board-of-radiology-pathway-to-dual-board-certifications-in-nuclear/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Adoption of the 16-Month American Board of Radiology Pathway to Dual Board Certifications in Nuclear Radiology and/or Nuclear Medicine for Diagnostic Radiology Residents</h3><div class="text-muted small"><p> We thank Dr Segall for his thoughtful comments and appreciate the opportunity to respond. Because our survey was conducted during the 2013–2014 academic year, the American Board of Radiology (ABR),...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/apparent-diffusion-coefficient-maps-integrated-in-whole-body-mri-examination-for-the-evaluation-of-t/" class="btn btn-outline-primary" prompt="Older"><p>Apparent Diffusion Coefficient Maps Integrated in Whole-Body MRI Examination for the Evaluation of Tumor Response to Chemotherapy in Patients with Multiple Myeloma</p></a> <a href="/posts/automated-tube-voltage-adaptation-in-combination-with-advanced-modeled-iterative-reconstruction-in-t/" class="btn btn-outline-primary" prompt="Newer"><p>Automated Tube Voltage Adaptation in Combination with Advanced Modeled Iterative Reconstruction in Thoracoabdominal Third-Generation 192-Slice Dual-Source Computed Tomography</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
